| Authors: |
Egger M; Dana-Farber Cancer Institute, Boston, MA, USA. megger@broadinstitute.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. megger@broadinstitute.org.; Hospital Center Biel-Bienne, Department of Urology, Biel-Bienne, Switzerland. megger@broadinstitute.org., D'Andrea VD; Dana-Farber Cancer Institute, Boston, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Urology, Harvard Medical School, Boston, MA, USA., Steiner C; Dana-Farber Cancer Institute, Boston, MA, USA.; University Hospital Leipzig, Department of Urology, Leipzig, Germany., Onochie NO; Dana-Farber Cancer Institute, Boston, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Urology, Harvard Medical School, Boston, MA, USA., Clinton TN; Dana-Farber Cancer Institute, Boston, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Urology, Harvard Medical School, Boston, MA, USA., Pan CX; Dana-Farber Cancer Institute, Boston, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA., Kibel AS; Dana-Farber Cancer Institute, Boston, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Urology, Harvard Medical School, Boston, MA, USA., Lee CT; Department of Urology, The Ohio State University Medical Center, Columbus, OH, USA., Mouw KW; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Radiation Oncology, Harvard Medical School, Boston, MA, USA., Mossanen M; Dana-Farber Cancer Institute, Boston, MA, USA.; Mass General Brigham, Brigham & Women's Hospital, Department of Urology, Harvard Medical School, Boston, MA, USA. |
